4Filed Jul 6, 8:00 PM ET
SOPHiA GENETICS (SOPH) CMO Philippe Menu Sells 7,393 Shares
$SOPH · SOPHiA GENETICS SAResearch Summary
AI-generated summary of this SEC filing
SOPHiA GENETICS (SOPH) CMO Philippe Menu Sells 7,393 Shares
What Happened Philippe Menu, Chief Medical Officer of SOPHiA GENETICS SA (SOPH), sold 7,393 shares on 2026-07-06 in open-market transactions. The filing reports a weighted-average price of $5.16 per share (range $4.97–$5.44), for total proceeds of approximately $38,156. This was a sale (routine cash outflow), not a purchase.
Key Details
- Transaction date: 2026-07-06; Form 4 filed: 2026-07-07 (appears timely).
- Reported price: weighted average $5.16; individual trades ranged $4.97–$5.44.
- Shares sold: 7,393; proceeds ≈ $38,156.
- Shares owned after transaction: Not disclosed in this filing.
- Footnotes: Sale executed pursuant to a pre-established Rule 10b5-1(c) trading plan and was done to satisfy tax withholding obligations arising from restricted stock units that vested on July 2 and July 3, 2026. The price shown is a weighted average; the filer can provide per-trade prices on request.
Context Sales to cover tax withholding on RSU vesting are common and are generally considered routine rather than a signal of changed insider sentiment. The transaction was executed under a 10b5-1 plan, meaning it was pre-scheduled and non-discretionary.